| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 674071 | Null | 0.0457230037898008 | -0.093942365 |
| NSC 676006 | Null | 0.0457230037898008 | -0.12422369 |
| NSC 676790 | Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-[4-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .beta.-L-arabinopyranos | 0.0457230037898008 | 0.0047458082 |
| NSC 677003 | Null | 0.0457230037898008 | 0.2780054 |
| NSC 678994 | 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- | 0.0457230037898008 | 0.090414293 |
| NSC 683856 | Null | 0.0457230037898008 | 0.1876 |
| NSC 684909 | 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer A)-, stereoisomer of NSC-684910 | 0.0457230037898008 | 0.1932966 |
| NSC 685844 | Null | 0.0457230037898008 | 0.12366932 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0457230037898008 | -0.079707822 |
| NSC 693622 | Null | 0.0457230037898008 | 0.30248569 |